Ocrelizumab May Affect Prognostic Value of JCV Antibody Index in Multiple Sclerosis
JC Virus index may not provide prognostic value in patients with multiple sclerosis treated with ocrelizumab for 2 years.
Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JC Virus index may not provide prognostic value in patients with multiple sclerosis treated with ocrelizumab for 2 years.
Baseline neurofilament light chain levels may predict clinical relapse and MRI lesion activity in patients with multiple sclerosis.
Real-world data show the safety and efficacy profile of oral cladribine for the treatment of relapsing-remitting multiple sclerosis.
Todos Medical Ltd majority-owned subsidiary 3CL Pharma Ltd has reported a Day 26 update from an ongoing 60-day case study of the dietary supplement 3CL...
Todos Medical Ltd majority-owned subsidiary 3CL Pharma Ltd has reported a Day 26 update from an ongoing 60-day case study of the dietary supplement 3CL...